Clinical trials
Observational Squamous Cell Carcinoma of Head and Neck trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chang Gung Memorial Hospital | 3 |
| M.D. Anderson Cancer Center | 3 |
| National Taiwan University Hospital | 3 |
| Assiut University | 2 |
| Sohag University | 2 |
| University Medical Center Groningen | 2 |
| AHS Cancer Control Alberta | 1 |
| Academisch Ziekenhuis Maastricht | 1 |
| Academy of Interdisciplinary Dental Education and Research | 1 |
| Armed Forces Institute of Pathology Rawalpindi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 52 |
| Head and Neck Neoplasms | 9 |
| Mouth Neoplasms | 8 |
| Oropharyngeal Neoplasms | 4 |
| Carcinoma, Squamous Cell | 3 |
| Neoplastic Cells, Circulating | 3 |
| Hypopharyngeal Neoplasms | 2 |
| Laryngeal Neoplasms | 2 |
| Neoplasms | 2 |
| Acrocephalosyndactylia | 1 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.